|
1
|
Tvedt THA, Steien E, Øvrebø B, Haaverstad R, Hobbs W, Wardęcki M, Tjønnfjord GE, Berentsen SA. Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery. Am J Hematol 2022; 97:E51-E54. [PMID: 34778998 DOI: 10.1002/ajh.26409] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 11/04/2021] [Accepted: 11/11/2021] [Indexed: 01/24/2023]
Affiliation(s)
- Tor Henrik A. Tvedt
- Department of Medicine Haukeland University Hospital Bergen Norway
- Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B‐cell malignancies, Institute of Clinical Medicine University of Oslo Oslo Norway
| | - Egil Steien
- Department of Anesthesia and Intensive Care Haukeland University Hospital Bergen Norway
| | - Bente Øvrebø
- Department of Anesthesia and Intensive Care Haukeland University Hospital Bergen Norway
| | - Rune Haaverstad
- Section of Cardiothoracic Surgery, Department of Heart Disease Haukeland University Hospital Bergen Norway
| | | | | | - Geir Erland Tjønnfjord
- Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B‐cell malignancies, Institute of Clinical Medicine University of Oslo Oslo Norway
| | | |
Collapse
|